Ankur Dhingra serves as Executive at CareDx, Inc., where they oversee executive responsibilities. Since joining the company, Ankur Dhingra has executed 13 insider transactions totaling $908.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 6, 2024 involved receiving (via award) 8,826 shares valued at $0.
Ankur Dhingra currently holds 8,826 shares of CareDx, Inc. (CDNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ankur Dhingra has been a net buyer of CDNA stock. They have purchased $908.8K and sold $0 worth of shares.
Ankur Dhingra's most recent insider trade was on May 6, 2024, when they sold 8,826 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.75 |
| Discretionary |
| Dec 13, 2023 | SMMT | $42.7K | Purchase | 19,700 | $2.17 | Discretionary |
| Dec 13, 2023 | SMMT | $1.5K | Purchase | 700 | $2.15 | Discretionary |
| Mar 7, 2023 | SMMT | $206.2K | Purchase | 196,362 | $1.05 | Discretionary |
| Aug 16, 2022 | SMMT | $12.6K | Purchase | 13,027 | $0.97 | Discretionary |
| Aug 16, 2022 | SMMT | $23.9K | Purchase | 24,658 | $0.97 | Discretionary |
| Aug 16, 2022 | SMMT | $11.2K | Purchase | 11,557 | $0.97 | Discretionary |
| Aug 16, 2022 | SMMT | $23.9K | Purchase | 24,658 | $0.97 | Discretionary |
| Mar 25, 2022 | CDNA | $47.5K | Payment | 1,254 | $37.90 | Discretionary |
| Feb 2, 2022 | CDNA | $0 | Award | 19,900 | $N/A | Discretionary |
| Nov 24, 2021 | CDNA | $211.7K | Purchase | 5,000 | $42.34 | Discretionary |
| Mar 25, 2021 | CDNA | $0 | Award | 14,500 | $N/A | Discretionary |